697.08
前日終値:
$694.70
開ける:
$688.72
24時間の取引高:
1.01M
Relative Volume:
1.12
時価総額:
$86.97B
収益:
$344.58B
当期純損益:
$2.83B
株価収益率:
31.92
EPS:
21.84
ネットキャッシュフロー:
$1.63B
1週間 パフォーマンス:
+2.61%
1か月 パフォーマンス:
+6.38%
6か月 パフォーマンス:
+37.03%
1年 パフォーマンス:
+32.54%
Mckesson Corporation Stock (MCK) Company Profile
名前
Mckesson Corporation
セクター
電話
972-446-4800
住所
6555 STATE HIGHWAY 161, IRVING, TX
MCK を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MCK
Mckesson Corporation
|
697.08 | 86.97B | 344.58B | 2.83B | 1.63B | 21.84 |
![]()
COR
Cencora Inc
|
286.74 | 55.07B | 303.19B | 1.40B | -638.10M | 7.03 |
![]()
CAH
Cardinal Health Inc
|
134.71 | 32.56B | 222.16B | 1.31B | -486.00M | 5.36 |
![]()
HSIC
Henry Schein Inc
|
64.73 | 8.04B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
OMI
Owens Minor Inc
|
6.93 | 534.60M | 10.42B | -38.77M | 323.54M | -0.51 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-04 | 再開されました | Mizuho | Neutral |
2024-11-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
2024-09-24 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2024-09-05 | 繰り返されました | Leerink Partners | Outperform |
2024-08-08 | 繰り返されました | Mizuho | Neutral |
2024-02-26 | 開始されました | Leerink Partners | Outperform |
2024-01-03 | 開始されました | Barclays | Overweight |
2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
2023-03-31 | 開始されました | Citigroup | Buy |
2022-08-22 | 再開されました | Morgan Stanley | Overweight |
2022-07-06 | ダウングレード | Argus | Buy → Hold |
2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
2022-04-01 | 再開されました | Credit Suisse | Outperform |
2022-02-04 | ダウングレード | Deutsche Bank | Buy → Hold |
2022-01-07 | アップグレード | Credit Suisse | Neutral → Outperform |
2021-11-02 | 繰り返されました | Barclays | Overweight |
2021-11-02 | 繰り返されました | BofA Securities | Buy |
2021-11-02 | 繰り返されました | Evercore ISI | Outperform |
2021-11-02 | 繰り返されました | Jefferies | Buy |
2021-03-30 | アップグレード | Argus | Hold → Buy |
2020-11-02 | アップグレード | Barclays | Equal Weight → Overweight |
2020-08-04 | アップグレード | Deutsche Bank | Hold → Buy |
2020-05-22 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2020-05-15 | アップグレード | UBS | Neutral → Buy |
2020-04-23 | 再開されました | Credit Suisse | Neutral |
2020-03-18 | アップグレード | Goldman | Neutral → Buy |
2020-03-13 | アップグレード | Guggenheim | Neutral → Buy |
2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
2020-01-10 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2019-09-12 | 開始されました | Deutsche Bank | Hold |
2019-08-05 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
2019-07-22 | 開始されました | Guggenheim | Neutral |
2019-01-17 | 開始されました | UBS | Neutral |
2018-10-26 | 繰り返されました | Barclays | Equal Weight |
2018-07-20 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2018-05-29 | 繰り返されました | Leerink Partners | Mkt Perform |
2018-03-08 | 開始されました | Barclays | Equal Weight |
2018-02-27 | 再開されました | BofA/Merrill | Buy |
2018-02-02 | 繰り返されました | Mizuho | Neutral |
2018-01-24 | アップグレード | Jefferies | Hold → Buy |
すべてを表示
Mckesson Corporation (MCK) 最新ニュース
Jim Cramer Labels McKesson Corporation (MCK) a “Money Machine – A Must-Own Middleman” - Insider Monkey
McKesson Careers | The future of health starts with you. - McKesson Careers
McKesson Launches Precision Care Companion for Biomarker-Driven Cancer Care - HIT Consultant
McKesson is medicine for Elite Investors in market chaos - Citywire
Jim Cramer’s List of 16 Stocks to Buy Right Now - Insider Monkey
Citigroup Adjusts Price Target on McKesson to $800 From $685, Maintains Buy Rating - marketscreener.com
McKesson provides Elite Investors with medicine for market choas - Citywire
McKesson (MCK) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
McKesson Launches Collaboration to Boost Precision Oncology Adoption - Inside Precision Medicine
McKesson (NYSE:MCK) Launches Precision Care Initiative Transforming Oncology Treatment - Yahoo Finance
Jim Cramer: McKesson (MCK) Is a “Money Machine” – Funds Keep Flowing In - Yahoo Finance
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology - Business Wire
McKesson Corporation (MCK): Among the Best Value Dividend Stocks to Buy According to Billionaires - Yahoo Finance
3 Dividend Stocks Built for Stability as Growth Trades Cool Off - Investing.com
Middlemen Always Work.” – Jim Cramer’s Love for McKesson Corporation (MCK) - Insider Monkey
GS1 US to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter
GS1 to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter
McKesson (MCK) Sees Price Target Boost to $755 by BofA | CAH Sto - GuruFocus
McKesson To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
McKesson and Wegmans: A Long-Standing Partnership in Advancing Pharmacy - NEWS CHANNEL NEBRASKA
Why the Market Dipped But McKesson (MCK) Gained Today - Yahoo Finance
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know - Yahoo Finance
Jonathan Jackson from Illinois’s 1st district makes notable trades in Microsoft, Salesforce, and McKesson - Investing.com India
This Medical Supplies Distributor Dodges A Tariff Bullet - Investor's Business Daily
Evercore ISI Adjusts Price Target on McKesson to $740 From $675, Maintains Outperform Rating - MarketScreener
McKesson (MCK) Stock Moves -1.38%: What You Should Know - Yahoo Finance
McKesson opens registration for 2025 ideaShare conference - Drug Store News
Registration Opens for Annual McKesson ideaShare Conference - Yahoo Finance
Quad-C Management Completes the Sale of PRISM Vision to McKesson - PR Newswire
Quad-C sells stake in Prism Vision to McKesson Corporation - pehub.com
McKesson Corporation (MCK): Jim Cramer’s Top Pick – Why He Thinks McKesson Can ‘Jack Prices Up’ - Insider Monkey
Zacks Research Brokers Lift Earnings Estimates for McKesson - Defense World
Rite Aid weighs repeat bankruptcy filing, WSJ reports - MarketScreener
McKesson In Huge Group New To IBD 50: Check Out Which Stocks Just Came On – And Off – IBD's Top Stock Screens - Investor's Business Daily
McKesson stock soars to all-time high of $726.13 By Investing.com - Investing.com South Africa
McKesson stock soars to all-time high of $726.13 - Investing.com
Mizuho raises McKesson stock target to $690, maintains neutral By Investing.com - Investing.com South Africa
MCK Stock Gains as PRISM Acquisition Adds High-Growth Business - TradingView
McKesson Corporation completed the acquisition of 80% stake in PRISM Vision Group from Quad-C Management, Inc. - MarketScreener
Deutsche Bank Adjusts Price Target on McKesson to $692 From $700, Maintains Buy Rating - MarketScreener
Mizuho Adjusts Price Target on McKesson to $690 From $630, Maintains Neutral Rating - MarketScreener
McKesson price target raised to $690 from $630 at Mizuho - TipRanks
Mizuho raises McKesson stock target to $690, maintains neutral - Investing.com India
McKesson Shares Up Over 2% After Key Signal - Benzinga
McKesson Gets Drugs to Patients. Buy the Stock for Healthy Returns. - Barron's
McKesson (MCK) Poised for Growth in Pharmaceutical Distribution - GuruFocus
Whistleblower Asks Justices to Revive Suit Against McKesson Unit - Bloomberg Law News
McKesson: Morgan Stanley's Top Choice For Pharmaceutical Gains - Finimize
McKesson Likely to See Strong Growth Amid Favorable Pharma Sector, Morgan Stanley Says - MarketScreener
McKesson completes $850M majority stake purchase in eye care company - The Business Journals
Mckesson Corporation (MCK) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):